{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T12:23:14Z","timestamp":1791116594773,"version":"4.1.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2007,2,1]],"date-time":"2007-02-01T00:00:00Z","timestamp":1170288000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2007,2]]},"DOI":"10.1007\/s00415-006-0298-5","type":"journal-article","created":{"date-parts":[[2007,2,20]],"date-time":"2007-02-20T15:29:28Z","timestamp":1171985368000},"page":"154-159","source":"Crossref","is-referenced-by-count":43,"title":["Evaluation of CSF-Chlamydia pneumoniae, CSF-tau, and CSF-Abeta42 in Alzheimer\u2019s disease and vascular dementia"],"prefix":"10.1007","volume":"254","author":[{"given":"Bogus\u0142aw","family":"Paradowski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malgorzata","family":"Jaremko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadeusz","family":"Dobosz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerzy","family":"Leszek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leszek","family":"Noga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2007,2,21]]},"reference":[{"key":"298_CR1","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1001\/archneur.56.6.673","volume":"56","author":"N Andreasen","year":"1999","unstructured":"Andreasen N, Hesse C, Davidsson P, et al. (1999) Cerebrospinal fluid b-Amyloid 1-42 in Alzheimer Disease: differences between early-and late-onset Alzheimer disease and stability during the course of disease. Arch Neurol 56:673\u2013680","journal-title":"Arch Neurol"},{"key":"298_CR2","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1001\/archneur.58.3.373","volume":"58","author":"N Andreasen","year":"2001","unstructured":"Andreasen N, Minnthon L, Davidsson P, et al. (2001) Evaluation CSF-tau and CSF-Abeta42 as diagnostic markers for Alzheimer disease in clinical practice. Arch Neurol 58:373\u2013379","journal-title":"Arch Neurol"},{"key":"298_CR3","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s004300050071","volume":"187","author":"BJ Balin","year":"1998","unstructured":"Balin BJ, Gerard HC, Arking EJ, et al. (1998) Identification and localization of Chlamydia pneumoniae in the Alzheimer\u2019s brain. Med Microbiol Immunol 187:23\u201342","journal-title":"Med Microbiol Immunol"},{"key":"298_CR4","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/0923-2494(92)80051-L","volume":"143","author":"J Bauer","year":"1992","unstructured":"Bauer J, Ganter U, Strauss SS, et al. (1992) The participation of interleukin-6 in the pathogenesis of Alzheimer\u2019s disease. Res Immunol 143:650\u2013657","journal-title":"Res Immunol"},{"key":"298_CR5","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1183\/09031936.04.00001004","volume":"23","author":"F Blasi","year":"2004","unstructured":"Blasi F, Centanni S, Allegra L. (2004) Chlamydia pneumoniae: crossing the barriers? Eur Respir J 23:499\u2013500","journal-title":"Eur Respir J"},{"key":"298_CR6","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1161\/01.CIR.100.13.1369","volume":"100","author":"R Dechend","year":"1999","unstructured":"Dechend R, Maass M, Gieffer J, et al. (1999) Chlamydia pneumoniae infection of vascular smooth muscle and endothelial cells activates NF-kappaB and induces tissue factor and PAI-1 expression: a potential link to accelerated arteriosclerosis. Circulation 100:1369\u20131373","journal-title":"Circulation"},{"key":"298_CR7","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1001\/archneur.55.7.937","volume":"55","author":"D Galasko","year":"1998","unstructured":"Galasko D, Clark C, Motter R, et al. (1998) High cerebrospinal fluid tau and low amyloid \u00df42 levels in the clinical diagnosis of Alzheimer disease and relation to apolipoprotein E genotype. Arch Neurol 55:937\u2013945","journal-title":"Arch Neurol"},{"key":"298_CR8","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1128\/JCM.30.4.796-800.1992","volume":"30","author":"CA Gaydos","year":"1992","unstructured":"Gaydos CA, Quinn TC, Eiden JJ. (1992) Identification of Chlamydia pneumoniae by DNA amplification of the 16S rRNA gene. J Clin Microbiol 30:796\u2013800","journal-title":"J Clin Microbiol"},{"key":"298_CR9","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1002\/ana.1020","volume":"49","author":"J Gieffers","year":"2001","unstructured":"Gieffers J, Pohl D, Treib J, et al. (2001) Presence of Chlamydia pneumoniae DNA in the cerebral spinal fluid is a common phenomenon in a variety of neurological diseases and not restricted to multiple sclerosis. Ann Neurol 49:585\u2013589","journal-title":"Ann Neurol"},{"key":"298_CR10","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1128\/JCM.38.2.881-882.2000","volume":"38","author":"J Gieffers","year":"2000","unstructured":"Gieffers J, Reusche E, Solbach W, et al. (2000) Failure to detect Chlamydia pneumoniae in brain sections of Alzheimer\u2019s disease patients. J Clin Microbiol 38:881\u2013882","journal-title":"J Clin Microbiol"},{"key":"298_CR11","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1183\/09031936.04.00093304","volume":"23","author":"J Gieffers","year":"2004","unstructured":"Gieffers J, van Zandbergen G, Rupp J, et al. (2004) Phagocytes transmit Chlamydia pneumoniae from the lung to the vasculature. Eur Respir J 23:506\u2013510","journal-title":"Eur Respir J"},{"key":"298_CR12","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1191\/1352458503ms944oa","volume":"9","author":"LM Grimaldi","year":"2003","unstructured":"Grimaldi LM, Pincherle A, Martinelli-Boneschi F, et al. (2003) An MRI study of Chlamydia pneumoniae in Italian multiple sclerosis patients. Mult Scler 9:467\u2013471","journal-title":"Mult Scler"},{"key":"298_CR13","first-page":"570","volume":"6","author":"RF Itzhaki","year":"2001","unstructured":"Itzhaki RF, Dobson CB, Lin WR, et al. (2001) Association of HSV-1 and apolipoprotein E-verepsilon4 in Alzheimer\u2019s disease. J Neurovirol 6:570\u2013571","journal-title":"J Neurovirol"},{"key":"298_CR14","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0140-6736(96)10149-5","volume":"349","author":"RF Itzhaki","year":"1997","unstructured":"Itzhaki RF, Lin WR, Shang D, et al. (1997) Herpes simplex virus type 1 in brain and risk of Alzheimer\u2019s disease. Lancet 349:241\u2013244","journal-title":"Lancet"},{"key":"298_CR15","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.neurobiolaging.2003.12.021","volume":"25","author":"RF Itzhaki","year":"2004","unstructured":"Itzhaki RF, Wozniak MA, Appelt DM, et al. (2004) Infiltration of the brain by pathogens causes Alzheimer\u2019s disease. Neurobiol Aging 25:619\u2013627","journal-title":"Neurobiol Aging"},{"key":"298_CR16","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1002\/jmv.1890330403","volume":"33","author":"GA Jamieson","year":"1991","unstructured":"Jamieson GA, Maitland NJ, Wilcock GK, et al.( 1991) Latent herpes simplex virus type 1 in normal and Alzheimer\u2019s disease brains. J Med Virol 33:224\u2013227","journal-title":"J Med Virol"},{"key":"298_CR17","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1046\/j.1468-1331.2003.00562.x","volume":"10","author":"E Kapaki","year":"2003","unstructured":"Kapaki E, Paraskevas GP, Zalonis I, et al. (2003) CSF tau protein and \u03b2-amyloid (1-42) in Alzheimer\u2019s disease diagnosis: discrimination from normal ageing and other dementias in the Greek population. Eur J Neurol 10:119\u2013128","journal-title":"Eur J Neurol"},{"key":"298_CR18","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1006\/nbdi.2001.0465","volume":"9","author":"WR Lin","year":"2002","unstructured":"Lin WR, Wozniak MA, Wilcock GK, et al. (2002) Cytomegalovirus is present in a very high proportion of brains from vascular dementia patients. Neurobiol Dis 9:82\u201387","journal-title":"Neurobiol Dis"},{"key":"298_CR19","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0197-4580(03)00127-1","volume":"25","author":"CS Little","year":"2004","unstructured":"Little CS, Hammond CJ, MacIntyre A, et al. (2004) Chlamydia pneumoniae induces Alzheimer-like amyloid plaque brains of BALB\/c mice. Neurobiol Aging 25:419\u2013429","journal-title":"Neurobiol Aging"},{"key":"298_CR20","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/j.1532-5415.2004.52109.x","volume":"52","author":"MB Loeb","year":"2004","unstructured":"Loeb MB, Molloy DW, Smieja M, et al. (2004) A Randomized, Controlled Trial of Doxycycline and Rifampin for Patients with Alzheimer\u2019s Disease. J Am Geriatr Soc 52:381\u2013387","journal-title":"J Am Geriatr Soc"},{"key":"298_CR21","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1002\/jnr.10519","volume":"71","author":"A MacIntyre","year":"2003","unstructured":"MacIntyre A, Abramov R, Hammond CJ, et al. (2003) Chlamydia pneumoniae infection promotes the transmigration of monocytes through human brain endothelial cells. J Neurosci Res 71:740\u2013750","journal-title":"J Neurosci Res"},{"key":"298_CR22","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1001\/archneur.60.9.1202","volume":"60","author":"A Maddalena","year":"2003","unstructured":"Maddalena A, Papassotiropoulos A, Muller-Tillmanns B, et al. (2003) Biochemical diagnosis of Alzheimer disease by measuring the cerebrospinal fluid ratio of phosphorylated tau protein to b-amyloid peptide 42. Arch Neurol 60:1202\u20131206","journal-title":"Arch Neurol"},{"key":"298_CR23","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/S0735-1097(98)00016-3","volume":"31","author":"M Maass","year":"1998","unstructured":"Maass M, Bartels C, Engel P, et al. (1998) Endovascular presence of viable Chlamydia pneumoniae is a common phenomenon in coronary artery disease. J Am Coll Cardiol 31:827\u2013832","journal-title":"J Am Coll Cardiol"},{"key":"298_CR24","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1161\/01.CIR.0000040403.57597.48","volume":"106","author":"FJ Neumann","year":"2002","unstructured":"Neumann FJ (2002) Chlamydia pneumoniae-atherosclerosis link: a sound concept in search for clinical relevance. Circulation 106:2414\u20132416","journal-title":"Circulation"},{"key":"298_CR25","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1001\/archneur.1988.00520310115025","volume":"45","author":"MD O\u2019Brien","year":"1988","unstructured":"O\u2019Brien MD (1988) Vascular dementia is underdiagnosed. Arch Neurol 45:797\u2013798","journal-title":"Arch Neurol"},{"key":"298_CR26","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.1128\/JCM.38.7.2591-2594.2000","volume":"38","author":"RH Ring","year":"2000","unstructured":"Ring RH, Lyons JM. (2000) Failure to detect Chlamydia pneumoniae in the late-onset Alzheimer\u2019s brain. J Clin Microbiol 38:2591\u20132594","journal-title":"J Clin Microbiol"},{"key":"298_CR27","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1023\/B:NERE.0000023612.66691.e6","volume":"29","author":"M Sadowski","year":"2004","unstructured":"Sadowski M, Pankiewicz J, Scholtzova H, et al. (2004) Links Between the Pathology of Alzheimer\u2019s Disease and Vascular Dementia. Neurochemical Research 29:257\u20131266","journal-title":"Neurochemical Research"},{"key":"298_CR28","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1093\/clinchem\/47.10.1776","volume":"47","author":"M Sj\u00f6gren","year":"2001","unstructured":"Sj\u00f6gren M, Vanderstichele H, Agren H, et al. (2001) Tau and A\u03b2 in cerebrospinal fluid from healthy adults 21\u201393 years of age: establishment of reference values. Clin Chem 47:1776\u20131781","journal-title":"Clin Chem"},{"key":"298_CR29","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1001\/jama.289.16.2094","volume":"289","author":"T Sunderland","year":"2003","unstructured":"Sunderland T, Linker G, Mirza N, et al. (2003) Decreased beta-amyloid1\u201342 and increased tau levels in cerebrospinal fluid of patients with Alzheimer disease. JAMA 289:2094\u20132103","journal-title":"JAMA"},{"key":"298_CR30","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1212\/WNL.59.1.142","volume":"59","author":"GS Taylor","year":"2002","unstructured":"Taylor GS, Vipond IB, Paul LD, et al. (2002) Failure to correlate C. pneumoniae with late onset Alzheimer\u2019s disease. Neurology 59:142\u2013143","journal-title":"Neurology"},{"key":"298_CR31","first-page":"506","volume":"10","author":"PS Walsh","year":"1991","unstructured":"Walsh PS, Metzger DA, Higuchi R. (1991) Chelex 100 as a medium for simple extraction of DNA for PCR-based typing from forensic material. Biotechniques 10:506\u2013513","journal-title":"Biotechniques"},{"key":"298_CR32","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1128\/9781555818203.ch7","volume-title":"Chlamydia: Intracellular Biology, Pathogenesis, and Immunity","author":"ME Ward","year":"1999","unstructured":"Ward ME (1999) Mechanisms of chlamydia-induced disease. In: . Stephens RS, eds. Chlamydia: Intracellular Biology, Pathogenesis, and Immunity, Washington D.C., ASM press, pp. 171\u2013210"},{"key":"298_CR33","first-page":"45","volume":"5","author":"HM Wisniewski","year":"1995","unstructured":"Wisniewski HM, Wegiel J. (1995) The neuropathology of Alzheimer\u2019s disease. Neuroimaging Clin N Am 5:45\u201357","journal-title":"Neuroimaging Clin N Am"},{"key":"298_CR34","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/S0197-4580(02)00236-1","volume":"24","author":"MA Wozniak","year":"2003","unstructured":"Wozniak MA, Cookson A, Wilcock GK, et al. (2003) Absence of Chlamydia pneumoniae in brain of vascular dementia patients. Neurobiol Aging 24:761\u2013765","journal-title":"Neurobiol Aging"},{"key":"298_CR35","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1111\/j.1532-5415.2005.53204.x","volume":"53","author":"H Yamamoto","year":"2005","unstructured":"Yamamoto H, Watanabe T, Miyazaki A, et al. (2005) High prevalence of Chlamydia pneumoniae antibodies and increased high-sensitive C-reactive protein in patients with vascular dementia. J Am Geriatr Soc 53:583\u2013589","journal-title":"J Am Geriatr Soc"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-006-0298-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00415-006-0298-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-006-0298-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,20]],"date-time":"2020-04-20T04:47:58Z","timestamp":1587358078000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00415-006-0298-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,2]]},"references-count":35,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007,2]]}},"alternative-id":["298"],"URL":"https:\/\/doi.org\/10.1007\/s00415-006-0298-5","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,2]]}}}